1177.HK Sino Biopharm
HK$5.50 +0.18%
Asia ·
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Hover to inspect. EOD data.
1D
+0.18%
YTD
-35.70%
P/E
—
P/B
—
ROE
—
Div yield
—
Beta
0.55
Market cap
—
RSI (14)
49
Next earnings
—
Previous session
close of Oct 9, 2026 · EOD, no live order bookOpen
HK$5.56
Close
HK$5.50
VWAP (n/a)
—
Day high
HK$5.87
Day low
HK$5.48
Volume
82.2M
VWAP = daily turnover ÷ volume — the volume-weighted average, the closest EOD read on where trading actually clustered. A true order book is live-only and needs a broker feed. Turnover/VWAP available for MOEX listings.
Latest headlines
Sino Biopharmaceutical Limited Unveils New Global Brand, SBP Group, to Accelerate International Expansion
Yahoo Finance · Aug 19
European Stocks Close Sharply Lower in Wednesday Trading; Oil Prices Spike as US-Iran War Reignites
Yahoo Finance · Jul 8
AstraZeneca, GSK intensify China ties with Sino Biopharm deals
Yahoo Finance · Jul 8
GSK plans to sell chronic hepatitis B drug in China through Sino Biopharm
Yahoo Finance · May 11
GSK cuts deal with Sino to broaden reach of hepatitis B drug
Yahoo Finance · May 11
GSK China Hepatitis B Alliance Puts Bepirovirsen And Valuation In Focus
Yahoo Finance · May 12
Headlines via Yahoo Finance · links open the source · not an endorsement.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell 1177.HK. Try it in the Lab to size a position and see the risk.